Health ❯ Pain Management

Analgesics

Drug Therapy Non-Opioid Analgesics Cyclobenzaprine Morbidity Non-Surgical Treatments Pain Relief Opioid Analgesics

ARPA-H Sets 18-Month Deadline for Human Trials of Knee Osteoarthritis Regeneration Therapies

The program backs regeneration rather than pain relief, with strict rules on trial diversity and pricing.

NIH Identifies DFNZ, a Nitazene Opioid That Eased Pain in Rats Without Breathing Risks

FDA Approves First New Fibromyalgia Treatment in 15 Years

María Julia Oliván Takes First Assisted Steps After Ethanol Stove Accident

Novel Non-Opioid Analgesic ADRIANA Advances to U.S. Phase II Trials